Skip to main content
Tracey L. Papenfuss, DVM, MS, PhD, Diplomate ACVP (Anatomic Pathology)

 

LinkedIn Profile

 

Education and Specialty Training

  • PhD, Ohio State University, Veterinary Biosciences (Experimental Pathology) 2007
  • Diplomate, American College of Veterinary Pathologists- Anatomic Pathology 2006
  • DVM, University of Minnesota 2000
  • MS, University of Minnesota, Molecular Veterinary Biosciences 1999
  • BS, University of Alaska Fairbanks, Biology and Wildlife, 1993

 

Expertise:

Dr. Tracey L. Papenfuss, D.V.M., Ph.D. (Immunology), D.A.C.V.P, is a Principal Pathologist and Immunotoxicology Scientific Advisor at MPI Research with expertise in immunology, immunopathology and immunotoxicology.  As both an immunologist and veterinary pathologist, Dr. Papenfuss integrates complicated data sets and collaborates with scientific colleagues to provide a thorough assessment of how novel therapies impact the immune system in preclinical drug development.  She has more than 15 years of specialized experience, including as a Director of an immunopathology and early discovery immunotherapeutics laboratory at The Ohio State University and as a pathologist in preclinical safety assessment at Charles River Laboratories.  In addition to supporting educational and training opportunities for students, Dr. Papenfuss is an adjunct faculty member in the College of Veterinary Medicine and College of Pharmacy and serves as a consultant for industry in early discovery and preclinical safety in drug development and engages with students, faculty and academic units interested in establishing effective partnerships and collaborations between industry and the University.  As numerous immunomodulatory therapies with subtle or unexpected immune effects continue to be developed, Dr. Papenfuss provides an integrated approach to assessing and mitigating risk in drug development.

 

Research and Professional Interests

  • Toxicologic and Experimental Pathology
  • Immunotoxicology and Immunopathology
  • Immunotherapeutics and Immune-Modulation
  • Translational Medicine

Share: